North America accounted for the highest share in the global orthopedic navigation system market by region. Besides, factors including the rising elderly population, high healthcare spending by the government, a well-established system of reimbursement, and the presence of reputable manufacturers in the region all support the expansion of the regional market.
New Delhi, Sept. 17, 2022 (GLOBE NEWSWIRE) -- Global Orthopedic Navigation System Market size is expanding at a robust double-digit growth rate during the forecast period, mainly due to the orthopedic navigation system’s innovativeness, aging world population, increasing number of joint reconstruction cases, rising healthcare costs, and high patient and healthcare professional awareness levels.
BlueWeave Consulting, a leading strategic consulting and market research firm, in its recent study, estimated Global Orthopedic Navigation System Market size at USD 1.87 billion in 2021. And BlueWeave forecasts Global Orthopedic Navigation System Market to grow at an impressive CAGR of 18.2% between 2022 and 2028 to reach a market size of USD 5.75 billion by 2028. Major growth factors for the Global Orthopedic Navigation System Market include an increasing demand for orthopedic therapies, surgeries including joint reconstruction, and solutions driven by the rapidly aging global population.
Global Orthopedic Navigation System Market - Technology Advancements
In the recent past, pedicle screw insertion efficiency was improved by using orthopedic navigation systems during orthopedic spinal surgery. Since then, it has grown in popularity among orthopedic surgeons and has emerged as a crucial tool for several orthopedic procedures, including spine, tumor, sports injury, reconstructive hip, and knee surgery. Orthopedic navigation systems are now made to provide surgeons with in-the-moment input on the operating field, allowing them to modify their surgical technique to enhance postoperative results and reduce intraoperative errors. Additionally, typical and conventional methods may not be accurate, precise, or repeatable. As a result, there is a greater need for the creation of an innovative orthopedic navigation system. This, in turn, is expected to accelerate the rate of expansion of the global orthopedic navigation system market.
Request for Sample Report @ https://www.blueweaveconsulting.com/report/orthopedic-navigation-system-market/report-sample
Global Orthopedic Navigation System Market - Rising Demand
Global orthopedic navigation system market is predicted to boom as a result of an aging population and an increase in joint reconstruction cases, rising healthcare costs, and high patient and healthcare professional awareness levels. Orthopedic disorders including osteoporosis, osteoarthritis, rheumatoid arthritis, and ligamentous knee injuries are becoming more common. The musculoskeletal system of the body, which consists of muscles, bones, joints, nerves, ligaments, cartilage, and tendons, is impacted by these diseases. Reduced range of motion, stiffness, edema, and muscle pain follow, is necessitating subsequent surgical intervention. In the coming years, it is projected that it would increase demand for orthopedic navigation systems. The CDC estimates that 54.4 million Americans (or 1 in 4) have some kind of arthritis, and that number is anticipated to rise to 78 million by the year 2040. It suggests that the adoption of navigation systems for orthopedic procedures would increase further in the near future.
Global Orthopedic Navigation System - By Application
The knee segment dominated the total market in 2021 and will continue to grow at a consistent CAGR over the coming years. The reasons for its dominance include an increase in total knee replacement surgeries and public knowledge of the benefits they provide. Further supporting factors for the segment growth include expanding uses in a variety of surgical circumstances, including revision knee replacement, patellofemoral arthroplasty, unicompartmental (partial) knee replacement, and total knee arthroplasty. The number of knee surgery procedures is projected to increase as a result of rising technological developments, such as minimally invasive procedures, together with the accessibility of enhanced implant materials, which will encourage segment expansion.
The spine segment, on the other hand, is projected to record growth at the fastest CAGR between 2022 and 2028. The prevalence of spinal problems is rising, which has led to an increase in the number of spine procedures. The main cause of death and morbidity due to spinal injuries is either neurological injury weakness or bony spine damage to the spinal nerves or spinal cord. To reduce persistent functional impairment, quick medical and surgical intervention is essential. Additionally, the incidence of sports injuries is rising, along with the number of falls and traffic accidents.
Please Visit the Press Release: https://www.blueweaveconsulting.com/press-release/global-orthopedic-navigation-system-market-surging-to-triple-its-size-touching-usd-5-75-billion-by-2028
Due to the availability of better infrastructure, high awareness levels, and supportive government initiatives relevant to the promotion of orthopedic navigation systems, North America accounted for the highest revenue share. Besides, factors including the rising elderly population, high healthcare spending by the government, a well-established system of reimbursement, and the presence of reputable manufacturers in the region all support the expansion of the regional market. Due to the high number of unmet clinical needs, the rise in government initiatives to increase patient awareness of minimally invasive procedures for replacement surgeries, and rising investments by manufacturers for the creation of affordable orthopedic navigation systems, Asia Pacific (APAC) is expected to record growth at the fastest rate from 2022 to 2028. As older people are more likely to develop orthopedic illnesses, APAC as a whole offers a sizable target market, with Japan, China, and India being the main regional contributors.
Impact of COVID-19 on Global Orthopedic Navigation System Market
Numerous industries have been disrupted by the 2019 coronavirus illness (COVID-19), which had also resulted in trade and supply chain constraints on a global scale. Many cases of this contagious illness, which ranges in severity from extremely mild to life-threatening, have been reported as a result of the COVID-19 pandemic. Outpatient visits to healthcare providers have reduced due to worries about contracting the virus. Patients are occasionally needed to present with negative COVID-19 test results even in the absence of symptoms before undergoing specific surgical procedures.
During lockdowns, hospitals might not have enough supplies to handle an unexpected patient inflow, forcing them to cancel elective treatments and rearrange ICU beds. Also, a number of procedures were postponed or canceled to protect the wellbeing of patients and personnel due to the high risk of infectious transmission among patients and healthcare professionals. However, to effectively handle these difficulties, carry out time-efficient surgery over long operative hours, and reduce the transmission of infectious diseases, the usage of surgical robots has expanded. The hospital business is anticipated to see an increase in cases that were delayed or postponed due to the pandemic as the pandemic is currently reaching its end in most nations. During the period in analysis, this is most likely to fuel the market for orthopedic navigation systems.
Don’t miss the business opportunity in the Global Orthopedic Navigation System Market. Consult our analysts to gain crucial insights and facilitate your business growth.
To increase their market penetration, the leading companies engage in a variety of activities, including the development of new products, distribution agreements, and growth plans. For instance, Stryker finalized the acquisition of Wright Medical in November 2020 in an effort to strengthen its position in the worldwide trauma and extremities market, offering considerable prospects to better results, accelerate innovation, and broaden patient access.
Smith+Nephew launched the RI.HIP Navigation for Total Hip Arthroplasty in July 2020. (THA). The FDA of the United States granted 510(k) approval for this product, and the CE Mark was certified for THA. These activities are expected to increase the level of competition in the market in the upcoming years. Leading companies in the global orthopedic navigation systems market include AG B. Braun Melsungen, Stryker, and Medtronic.
In November 2020, Stryker completed the acquisition of Wright Medical, a US-based global medical device company with expertise in extremities and biologics, to strengthen its position in the global trauma and extremities market. The acquisition of Wright Medical is expected to enable Stryker to accelerate innovations and broaden patient access.
North America, Europe, Asia Pacific, Latin America, Middle East and Africa
By Technology, By Practice, By End User, By Region
B. Braun Melsungen AG, Stryker, Medtronic, Johnson & Johnson, Smith & Nephew Plc, Zimmer Biomet, Amplitude Surgical, Kinamed Inc., Globus Medical, Orth Align
Please Find Below Some New Reports:
Artificial Cornea and Corneal Implant Market -Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2018–2028
Clinical Chemistry Analyzers Market- Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2018–2028
Urinary Catheters Market - Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2018–2028
Peptide and Anticoagulant Drugs Market- Global Industry Size, Share, Trend Analysis and Forecast Report, 2018-2028
Point of Care (PoC) Infectious Disease Testing Market - Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2018–2028
BlueWeave Consulting provides comprehensive Market Intelligence (MI) Solutions to businesses regarding various products and services online and offline. We offer all-inclusive market research reports by analyzing both qualitative and quantitative data to boost the performance of your business solutions. BWC has built its reputation from scratch by delivering quality inputs and nourishing long-lasting relationships with its clients. We are one of the promising digital MI solutions companies providing agile assistance to make your business endeavors successful.
BlueWeave Consulting & Research Pvt. Ltd
info@blueweaveconsulting.com https://www.blueweaveconsulting.com/ https://www.linkedin.com/company/blueweaveconsulting/
We can readily understand why investors are attracted to unprofitable companies. For example, although...
The latest episode in this trend is brought to us by YouTube, which introduced a feature for creators to reply to comments on their videos with new Shorts. "Invite your audience to connect with you via this new feature by answering their questions in your Shorts, taking content requests, reacting to comments in your videos, and whatever else you come up with," the company said in a post. This could be pretty handy for creators who might want to respond to some fans' comments on a video as a follow-up.
Don't you hate it when people keep long lists of pet peeves? To catch full episodes of all The Motley Fool's free podcasts, check out our podcast center. David Gardner: Are you impressed when you see a movie is based on a true story?
The board of The North West Company Inc. ( TSE:NWC ) has announced that it will be paying its dividend of CA$0.38 on...
While Titanium Transportation Group Inc. ( TSE:TTR ) might not be the most widely known stock at the moment, it led the...
The board of Argan, Inc. ( NYSE:AGX ) has announced that it will pay a dividend on the 31st of October, with investors...
(Bloomberg) -- What’s buzzing on social media this morning:Most Read from BloombergBezos Loses Spot as World’s Second-Richest Person to AdaniPutin Threatens New Military Strikes on Ukraine InfrastructureThere’s an Unusual Thing Happening in the Housing MarketPatagonia Billionaire Who Gave Up Company Skirts $700 Million Tax HitTrump Special Master Off to a Fast Start in Documents ReviewBUZZING HEADLINES:The argument over Florida Governor Ron DeSantis’s contentious flight of Venezuelan asylum seek
Of the 225 million Americans who are fully vaccinated, a mere 6,278 received Novavax. It's more popular in other countries like Japan and Australia, where it's used as a booster.
Nvidia Corp. faces a very different environment versus two years ago when it last launched a new chip architecture, one where demand is falling and its stock price has been more than halved over the year.
We’re getting toward the tail end of the year, and it’s time to start deciding just how to allocate the portfolio for a solid year-end return. In a recent note from JPMorgan, focused on the energy sector, 5-star analyst Arun Jayaram recommended oil and gas producers as likely to beat the overall markets going forward. Getting quickly to the bottom line, Jayaram states, "We remain fans of the longer-term story for natural gas driven by a growing global demand for low cost U.S. gas exports." With
You can't guess the bottom. But a bargain is a bargain.
Stocks have been under a lot of pressure this year, weighed down by rising interest rates to combat inflation. If there's a silver lining to the sell-off, dividend yields move inversely to stock prices. Because of that, many dividend yields are much higher right now.
Struggling Bed Bath & Beyond Inc. releases a list of dozens of stores it aims to close. Most of the stores on this list will close by the end of the month.
Essentially, it's having a killer business model that doesn't need to change much to stay profitable, relevant, and rewarding for shareholders as the years roll by. With that thought in mind, let's examine a trio of stocks worth buying and holding forever -- and you've probably already heard of all three. Abbott Laboratories (NYSE: ABT) is a no-brainer stock for indefinite holding because it's always growing its dividend and making share repurchases to boost returns.
Biotech companies with few products on the market and red ink on the bottom line may not look like the most attractive investments right now. Here are two biotech stocks to consider buying that could make investors richer in time: Axsome Therapeutics (NASDAQ: AXSM) and CRISPR Therapeutics (NASDAQ: CRSP). Axsome Therapeutics is fresh off an important regulatory milestone.
In this article, we will take a look at the 10 Blue Chip Stocks to Buy Now According to Billionaire Ray Dalio. To skip our analysis of Ray Dalio’s profile, investment strategy, and 13F holdings, you can go directly to see the 5 Blue Chip Stocks to Buy Now According to Billionaire Ray Dalio. With […]
After three months of highly volatile trading, which have seen the S&P 500 drop down toward 3,600, rally up to 4,300, and fall back down to 3,900, investors can be forgiven for feeling some whiplash. The question that needs answering, however, is where will the markets go from here? Morgan Stanley strategist Andrew Slimmon believes that investors shouldn’t worry too much about the bear case. Worse-than-expected inflation numbers for August may have pushed the markets into a tumble this week, but
Annaly Capital Management (NLY) closed at $6.04 in the latest trading session, marking a -1.63% move from the prior day.
Income investors are always on the hunt for good stocks that for one reason or another have recently been out of favor, creating a scenario for a higher dividend yield along with possible future appreciation as the stock bounces back. Buying a stock on a decline sometimes involves a bit of courage, but the ability to lock in long-term higher yields makes the decision easier for most investors. At the moment, Medical Properties Trust Inc. (NYSE: MPW), a Birmingham, Alabama-based real estate inves
For four days running, shares of industrial giant General Electric (NYSE: GE) have gone nowhere but down, including a 3.7% decline on Friday. Partially, that downward pressure has come from inflation and rising interest rates, and partially from the possibility that its labor costs will rise. Its really big problem is in the supply chain.